This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Supermodel Janice Dickinson Teams Up With Blue Horizon Stem Cells For Launch Of Special Skin Serum

NEW YORK, Nov. 8, 2013 /PRNewswire/ -- Supermodel Janice Dickinson and Blue Horizon Stem Cells have announced the launch of a new skin care product, Special Skin Serum.  Initial shipments of the serum, which have recently been made available for worldwide pre-order on www.bluehorizonskincare.com, have been set for the first week of December.

"My skin is just amazing," said Dickinson, self-professed supermodel pioneer.  "My face, my legs, my hands and my feet...everything got so smooth.  My life has improved tremendously."

While Special Skin Serum does not contain actual stem cells, it is derived from the same proprietary process used to treat patients in Blue Horizon Stem Cells' worldwide research facilities.  The company's team of health care experts and scientists say that this particular serum stands to revolutionalize the skin care industry, as it is one of the most potent anti-aging cocktails on the international market.

"The serum not only refreshes peptides and boosts elastin; it also delivers key protein-activating cytokines, short-and-long-chained hyaluronic acids and EGF growth-factors to the skin," said Dr. Brian Mehling, founder of Blue Horizon Stem Cells.

Such progress is no stranger to controversy, however.  Companies involved in stem cell research have increasingly come under fire in recent years amid doubts of ethical legitimacy.

"We do not and will not ever engage in embryonic or fetal stem cell research," said Mehling.  "Special Skin Serum is a potent anti-aging innovation, but it has been safely formulated in conjunction with years of non-embryonic stem cell research."

Blue Horizon Stem Cells, a subsidiary of Blue Horizon International, provides stem cell therapy and research to patients worldwide; and has safely and efficiently performed over 2,000 documented procedures.  The program is associated with the Stem Cell Centre, Hongqiao Brain Hospital, China's Wuhan University School of Basic Medical Science and Slovakia's Medissimo Hospital.  For more information visit www.bluehorizonstemcells.com.

Media Contact: Doreen Santora917-602-0942

Photos: http://www.prlog.org/12238962

SOURCE Blue Horizon International

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs